A influenza vaccine of first type H 1 N of our country begins to go into operation formally

A influenza vaccine of first type H 1 N of our country begins to go into operation formally
A influenza vaccine of first type H 1 N of our country begins to go into operation formally
Since obtaining a influenza vaccine of first type H 1 N and producing and using the poisonous Corporation, many of vaccine manufacturing enterprise of our country has put into reseach and production of vaccine immediately. Some enterprises have already begun to go into operation formally successively at present. Beijing department revitalize company, finish first type the intersection of H and the intersection of 1 N and 1 influenza vaccine seed criticize and prepare to work smoothly, and puts the first batch of vaccine into operation formally on June 15. Blue biological engineering Limited Company of China has already built up a poisonous kind of storehouses of a influenza vaccine of first type H 1 N too before this, and enter the production stage of vaccine formally. It is reported separately, refined favourable peak bio-pharmaceuticals Co., Ltd. of Dalian, Changchun the intersection of long life and the intersection of biotechnology and the intersection of Co., Ltd.,etc. and the intersection of vaccine and manufacturing enterprise get vaccine produce, spend malicious from the intersection of World Health Organization and approved laboratory too recently, combine development and production work of vaccine at the beginning. It is introduced, poisonous one that vaccine enterprises get from WHO is mixing a primitive seed of poison again, there is less quantity, can't satisfy and produce vaccine in batches, so must dilute it, then amplify and train, prepare the virus seed to criticize, this course takes seven eight days. Criticize the intersection of vaccine and production, need, go through the intersection of virus and inoculate, the intersection of virus and train, the intersection of virus and deactivate, purification, matching, assign, pack and criticize the intersection of person who issue and step, come into operation finally also only. The national food medicines press spokesman of supervision bureau Yan JiangYing says, first type H 1 N 1st influenza is a new kind of virus, vaccine lacks crowd's large-scale safety and validity data, can't be only eager at present vaccine is listed. After vaccine is produced out, still need to carry on the strict clinical experiment, the national food medicines supervision bureau will organize and coordinate every relevant department, links such as research and development, producing, examining, circulation, using of a influenza vaccine of first type H 1 N,etc. are supervised in the whole journey, most important also ensuring vaccine is safe and effective and quality is controllable. (reporter Zhou TingYu, Cui Jing)


|